First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the international metastatic renal cell carcinoma database consortium (IMDC).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jose Manuel Ruiz Morales, Marcin Swierkowski, Connor Wells, Anna Paola Fraccon, Francesca La Russa, Frede Donskov, Georg A. Bjarnason, Jae-Lyun Lee, Hao-Wen Sim, Benoit Beuselinck, Lori Wood, Takeshi Yuasa, Carmel Jo Pezaro, Brian I. Rini, Cezary Szczylik, Toni K. Choueiri, Daniel Yick Chin Heng
Institutions: University of Calgary, Wojskowy Instytut Medyczny, Ospedale P. Pederzoli – Casa di Cura Privata S.p.a., University of Verona, Aarhus University Hospital, Sunnybrook Health Science Centre, University of Toronto, Odette Cancer Centre, Asan Medical Center, University of Ulsan, Peter MacCallum Cancer Centre, Universitair Ziekenhuis Leuven, Queen Elizabeth II Health Sciences Centre, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Cleveland Clinic, Dana-Farber Brigham Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4241692891